Related Experiment Video
Updated: Mar 23, 2026
An Experimental Paradigm for the Prediction of Post-Operative Pain PPOP
Published on: January 27, 2010
Multidisciplinary assessment of congenital insensitivity to pain syndrome
Vugar Nabiyev1, Ateş Kara2, M Cemalettin Aksoy3
1Department of Orthopaedics and Traumatology, School of Medicine, Hacettepe University, Altindag, 06100, Ankara, Turkey.
Insights
Congenital insensitivity to pain and anhidrosis (CIPA) is a rare genetic disorder. Early recognition and patient education are key for managing CIPA, focusing on preventing injuries and infections.
Area of Science:
- Genetics
- Neurology
- Pediatrics
Background:
- Congenital insensitivity to pain and anhidrosis (CIPA) is a rare autosomal recessive disorder.
- Characterized by the absence of pain and temperature sensation, with impaired sweating.
- Affects the peripheral nervous system, despite intact central and peripheral nervous systems.
Observation:
- Two pediatric CIPA cases are presented: a 13-year-old girl with osteomyelitis and a 10-year-old boy with hand lesions and osteomyelitis.
- Both patients presented with severe complications, including joint destruction and bone infections.
- Treatment involved surgical debridement and intravenous antibiotics.
Findings:
- CIPA diagnosis requires early recognition due to its rarity and severe consequences.
- Management focuses on preventing injuries and infections, not a cure.
- No standardized treatment protocols exist for CIPA.
Implications:
- Highlights the importance of early diagnosis and multidisciplinary management for CIPA patients.
- Emphasizes the critical role of family education and patient training in preventing complications.
- Underscores the need for further research into standardized treatment guidelines for this rare condition.
Background:
Congenital insensitivity to pain and anhidrosis (CIPA) is a rare clinical condition characterized by the absence of normal subjective and objective responses to noxious stimuli in patients with intact central and peripheral nervous systems.
Case Presentations:
Two patients with CIPA are reported. The first patient was a 13-year-old girl who presented to our hospital with multiple joint destructions secondary to osteomyelitis. The second patient was a 10-year-old boy who presented with multiple hand lesions and right leg osteomyelitis. Our patients were treated with multiple debridements and intravenous antibiotics according to our hospital protocol.
Conclusion:
Early recognition of the disease is important. The treatment for this condition is focused more on the prevention of bone injuries and joint infection, as opposed to a cure. There are no standard techniques or guidelines available to treat this rare disease. Overall, effective CIPA treatment is built around family education and patient training.
